Nuvation Bio Inc logo

Nuvation Bio Inc

(Delisted) $ 5.44 +0.175 (+3.33%) 03:32 PM EST
P/E:
At Loss
P/B:
1.58
Market Cap:
$ 1.19B
Enterprise V:
$ 1.11B
Volume:
473.63K
Avg Vol (2M):
916.77K
Volume:
473.63K
Market Cap $:
1.19B
PE Ratio:
At Loss
Avg Vol (2-Month):
916.77K
Enterprise Value $:
1.11B
PB Ratio:
1.58
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Compare
Compare
Traded in other countries / regions
NUVB.USA
Description
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 250.54
Equity-to-Asset 0.96
Debt-to-EBITDA -0.03
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 45.47
9-Day RSI 42.05
14-Day RSI 39.8
6-1 Month Momentum % -33.91
12-1 Month Momentum % -39.18

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 45.62
Quick Ratio 45.62
Cash Ratio 45.22

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
ROE % -13.44
ROA % -12.9
ROIC % -306.45
ROC (Joel Greenblatt) % -4887.68
ROCE % -14.09

Financials (Next Earnings Date:2022-11-10 Est.)

NUVB's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NYSE:NUVB

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.44
Beta 0
Volatility % 58.42
14-Day RSI 39.8
14-Day ATR ($) 0.398953
20-Day SMA ($) 5.4615
12-1 Month Momentum % -39.18
52-Week Range ($) 4.46 - 15.23
Shares Outstanding (Mil) 219.06

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Nuvation Bio Inc Filings

Document Form Filing Date
No Filing Data

Nuvation Bio Inc Analysis

Share your research

Headlines

See More
No news.